Literature DB >> 33738054

Novel Oxopyrido[1,2-a]pyrimidine Compounds for Treating Bacterial Infection.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 33738054      PMCID： PMC7957911          DOI： 10.1021/acsmedchemlett.1c00077

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

Review 1.  Recent advancements in the medicinal chemistry of bacterial type II topoisomerase inhibitors.

Authors:  Shalini Jaswal; Bhupender Nehra; Shubham Kumar; Vikramdeep Monga
Journal:  Bioorg Chem       Date:  2020-09-03       Impact factor: 5.275

Review 2.  Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs.

Authors:  Emma Baglini; Silvia Salerno; Elisabetta Barresi; Marco Robello; Federico Da Settimo; Sabrina Taliani; Anna Maria Marini
Journal:  Eur J Pharm Sci       Date:  2020-10-12       Impact factor: 4.384

Review 3.  Recent advances in DNA gyrase-targeted antimicrobial agents.

Authors:  Satish N Dighe; Trudi A Collet
Journal:  Eur J Med Chem       Date:  2020-04-28       Impact factor: 6.514

Review 4.  Two Decades of Successful SAR-Grounded Stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs).

Authors:  Anja Kolarič; Marko Anderluh; Nikola Minovski
Journal:  J Med Chem       Date:  2020-02-17       Impact factor: 7.446
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.